CTOs on the Move

Nanoscope Therapeutics

www.nanostherapeutics.com

 
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Juvenon Inc

Juvenon Inc is a Orinda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AmeriWaste Medical Services

AmeriWaste Medical Services is a Lakewood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oklahoma Blood Institute

Oklahoma Blood Institute is the ninth largest, non profit blood center in America. More than 125,000 donors provide more than 250,000 gifts of blood yearly for transfusion and associated clinical services. OBI employs nearly 700 Oklahomans and works with an estimated 800 volunteers and 2,600 drive coordinators

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines. We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines. We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies. Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.

Accolade

We`re the only on-demand healthcare concierge for employers, health plans and health systems. Join our customers who experience industry-leading engagement levels, satisfaction scores unseen in health care, better health outcomes, and substantial medical cost savings of more than 10 percent. Our team of compassionate, trusted professionals, supported by breakthrough science and technologies guide consumers through the healthcare system in a deeply personalized manner. We`ve been recognized as one of the nation`s 25 most promising companies by Forbes magazine, the fastest-growing private healthcare company by Inc. 500, and a top workplace by multiple news publications.